Centre To Push Pharma Exports To Japan

Hyderabad: The Centre will give a special push to Indian pharma exports to Japan in the upcoming investment and trade promotion road show to be held from October 25 to 27 in Tokyo.

The roadshow will be led by the Union Minister for Commerce and Industries Piyush Goyal to promote India as an attractive investment destination and to promote Indian products in Japan. “In this context, pharmaceuticals and biomedical-related sectors have been identified as potential sectors for trade promotion in consultation with our Mission Japan,’‘ R Uday Bhaskar, Director-General, Pharmaceuticals Export Promotion Council (Pharmexcil) told businessline.

After the US and China, Japan is the third largest pharma market in the world, and would offer huge potential for Indian drug exporters, the Pharmexcil DG said. Pharmaexcil also asked its members to participate in the B2B meetings scheduled to be held on October 25.

India’s pharma exports to Japan stood at $247.50 million in 2022-23, with a growth rate of 3.79 percent compared to the previous financial year, Ravi said.

Related Posts

  • Pharma
  • May 20, 2025
  • 64 views
Zydus Wellness posts 30% profit growth in FY25, Q4 net sales up 17% YoY

For the quarter ended March 31, 2025, Zydus Wellness reported 17% year-on-year growth in net sales at ₹9,106 million, up from ₹7,780 million in Q4 FY24. Adjusted net profit after…

  • Pharma
  • May 20, 2025
  • 62 views
Lupin to boost complex generics in US, EU; eyes chronic growth in India

Lupin, which plans to develop the specialty business, is eyeing higher revenue share from its complex generics portfolios in the US and Europe. Moreover, with a pipeline of over 200…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Zydus Wellness posts 30% profit growth in FY25, Q4 net sales up 17% YoY

Zydus Wellness posts 30% profit growth in FY25, Q4 net sales up 17% YoY

Lupin to boost complex generics in US, EU; eyes chronic growth in India

Lupin to boost complex generics in US, EU; eyes chronic growth in India

Growth Triggers Line Up for Divi’s Labs

Growth Triggers Line Up for Divi’s Labs

From generic drugs to vaccines, Indian pharma industry is transforming lives worldwide

From generic drugs to vaccines, Indian pharma industry is transforming lives worldwide